Channel
@bdragon0808
On this record: Growth · Engagement · Posts · Citations · Cite this entry
13,276subscribers
+35 since we began measuring on 7 August 2026
Risers and fallers across the register · movement among entries of 10,000–31,623.
| Telegram ID | -1001476949503 |
|---|---|
| Type | Channel |
| Username | @bdragon0808 |
| Created | 5 April 2020 — measured — cross-checked against a third-party dataset (ext.tg_channel) |
| First recorded | 7 August 2026 |
| Last confirmed live | 14 August 2026 |
| Measurements held | 8 |
| Confirmed unchanged | 1 time, most recently 14 August 2026 |
| On Telegram | t.me/bdragon0808 |
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 14 Aug 2026, 14:27 | 13,276 | +3 |
| 13 Aug 2026, 08:15 | 13,273 | +26 |
| 12 Aug 2026, 09:38 | 13,247 | +5 |
| 11 Aug 2026, 10:46 | 13,242 | -1 |
| 9 Aug 2026, 09:11 | 13,243 | +3 |
| 8 Aug 2026, 08:31 | 13,240 | -1 |
| 7 Aug 2026, 10:45 | 13,241 | no change |
| 7 Aug 2026, 09:02 | 13,241 | first reading |
49 posts held, back to 31 July 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 18 pagesof Telegram’s post history, 20 posts per page.
ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.
ER is defined industry-wide as (forwards + reactions + comments) ÷ views— note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate.
| Window | Rolling 30 days · latest post in window 13 August 2026 |
|---|---|
| Posts held | 49 (31 July 2026 – 13 August 2026) |
| Views total | 128,176 |
| Reactions total | — |
| Forwards / comments | not exposed by the public surface — not measured, not estimated |
| Readings taken | 13 Aug 2026, 17:47 UTC |
Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.
Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.
Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.
큐렉소 반기 보고서 발표에 따른 부문별 실적 안내 드립니다. 이번 반기 부문별 사업실적은 의료로봇 사업부문이 1분기 기저효과로 급성장 하며 반기 기준 12.0% 의 부문 성장을 나타냈으며, 임플란트 사업부문 역시 반기기준 17.6% 성장 의료사업 부분 성장세가 두자릿수 성장을 이어가고 있습니다. 다만 식품원재료 무역 사업부문은 1.5% 성장을 보여 전체 매출액 증가에 도움이 되진 못하였고, 전체 매출증가는 반기기준 전년대비 8.8% 증가 하였습니다. 영업이익은 전년동기 대비 의료로봇 사업부문이 흑자 전환 한 것이 영업이익 증가에 영향을 주어 반기 기준 3.8%, 2분기 기준 10.3%로 이익증가세를 보이고 있습니다. 실적에 대한 사항은 첨부한 보도자료를 참고해 주시고 궁금한점 있으시면 문의 부탁 드립니다. 감사합니다. https:/…
https://www.thebionews.net/news/articleView.html?idxno=27081
병원도 마음대로 못가나요 https://www.dailymedi.com/news/news_view.php?wr_id=939320
실패 https://www.biospectator.com/news/view/29530
https://www.thebionews.net/news/articleView.html?idxno=27178
수술로봇이 단 200대만 깔려도 ISRG대비 2% 수준 이니, 적정시총은 6조라는 분석
리센스메디컬 홈뷰티 디바이스 팜 https://n.news.naver.com/article/015/0005309684?sid=101
경험상 대박나는 주식은 수준있는 블로그 분석글이 많음 https://m.blog.naver.com/journalist9/224291612282 https://blog.naver.com/deepflow_research/224291149183
바이오솔루션 https://n.news.naver.com/article/008/0005399380?sid=101
내용이 재미있음 읽어보시길 https://blog.naver.com/deepflow_research/224291149183
2026년 08월 13일(목) Daily News 로미플레이트 1차 급여 이후 남은 과제…"6개월 투여 충분치 않아" 글로벌 바이오헬스 투자 ‘선택과 집중’…7월 거래액 55%↑·VC 6%↓ 환자 알 권리 vs 필수의료 위축… 복지부, 의료사고 이력 공개에 '우려' 경구 비만 확장 속 주사제 선호 여전…‘마운자로’ 의료진 만족도 1위 CMG제약, 10월 주식병합 변경상장…"관리종목 지정 우려 해소" 제이투케이바이오, 2Q 매출 156억원으로 분기 최대…영업익 286% 급증 피플바이오, ‘알츠온 플러스’ FDA 혁신의료기기 지정 승인 임상 2상서 혈관운동증상 빈도‧중증도 괄목 감소 엑세쏘바이오파마, 패혈증 등 멀티 적응증 ‘신약 플랫폼’ 개발 착수 "68% 약가가산, 남 얘기"...자큐보로 본 신약개발 기업들의 딜레마 한국비…
메모리 + 바이오 + 코스닥 !
Showing the 12 most recent of 49 posts we hold for @bdragon0808. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Citation-graph rank — 325,791 of 1,340,412entries in the measured graph. A weighted position computed from the forward and mention edges below — republished posts weigh more than named mentions — and recomputed periodically, over the whole graph. Published only as this ordinal position, never as a score: a position is a fact, and a score printed beside one channel’s name would read as a verdict this register does not make. The two counts beneath stay separate for the same reason mentions are never summed with forwards anywhere else on this page — a named-by count costs nothing to manufacture. The top 100 by this measure, or how it is computed.
Republished by
Channels on the register that have forwarded this channel's posts into their own feed.
Republishes
Channels on the register whose posts this channel has forwarded.
Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.
Names
Channels on the register whose handles appear in this channel's posts.
A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 14 August 2026 — this entry's latest reading, not the date you are reading this.
“한양증권 제약/바이오 오병용” (@bdragon0808), 13,276 subscribers as measured 14 August 2026. Telegram Register, tgregister.com/channel/bdragon0808.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.